A Biopharmaceutical company based in Los Angeles and founded in 2007 that develops therapeutics and technologies using nanotechnology for cancer and other critical illnesses.
| CAGE Code | 55BH6 |
|---|---|
| Company Operating Status | Closed |
| Previous Name | New Abraxis, Inc. |
| Public/Private | Public |
| Wellfound ID | abraxis-bioscience |
| Wikidata ID | Q4669505 |